Skip to content

Establishing Mechanical Thrombectomy at a Limited-volume Stroke Center - Effects on Patient Morbidity and Mortality

Establishing Mechanical Thrombectomy at a Limited-volume Stroke Center - Effects on Patient Morbidity and Mortality.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04942041
Enrollment
300
Registered
2021-06-28
Start date
2021-01-01
Completion date
2026-12-31
Last updated
2023-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke, Acute Ischemic

Keywords

Stroke, Thrombectomy, Simulation, Quality program

Brief summary

The regional health authorities of South-East Norway has commissioned Sørlandet Hospital (SSHF), Norway to establish mechanical thrombectomy in large-vessel occlusion stroke. SSHF is a limited volume stroke center, and introduction of thrombectomy may impose quality challenges. Therefore the implementation will be guided by a simulation based quality assurance program. In this study, we will monitor timelines, technical and clinical outcomes, including adverse events.

Detailed description

In acute stroke, two million neurons are lost per minute. Thrombectomy is the treatment of choice for large vessel occlusion stroke: Each minute saved from stroke onset to successful thrombectomy on average extends the healthy life of young patients by a week. Also, more patients may have a thrombectomy option with early treatment, as the time window for thrombectomy is limited. In 2019, Sørlandet Hospital Kristiansand (SSK) established thrombectomy for stroke. This spared SSK patients from an over 300 km transport to the comprehensive thrombectomy center in Oslo. Avoiding delays due to long transports may lead to lower morbidity and mortality. However, SSK is a non-university hospital with a limited patient volume, which may contribute to inferior results. To compensate for this, the implementation of thrombectomy at SSK is guided by a national quality program, which includes systematic skill training, simulation team training and continuous local guideline updates. The primary objective of this observational study is to find out if implementation of thrombectomy at SSK, guided by the quality program, reduces patient morbidity and mortality. Long transfer times from smaller hospitals to comprehensive thrombectomy centers pose a major problem for the global stroke community. Thus, our results could be generalizable. Main aim: • To determine potential changes in patient morbidity and mortality after introduction of thrombectomy at SSK Secondary aims: * To describe associated time periods based on stroke onset, hospital arrival, thrombectomy start, end of procedure * To document technical outcomes of mechanical thrombectomies performed at SSK, i.e. degree of reperfusion after thrombectomy * To document complication rates during mechanical thrombectomies performed at SSK * To describe the implementation of the quality program at SSK * To document performance of simulator skill training over time

Interventions

OTHERSimulation based quality program

Stroke team simulation. Virtual reality task training simulation.

Sponsors

South-Eastern Norway Regional Health Authority
CollaboratorOTHER
Helse Stavanger HF
CollaboratorOTHER_GOV
University of Stavanger
CollaboratorOTHER
Sorlandet Hospital HF
Lead SponsorOTHER_GOV

Study design

Observational model
CASE_CONTROL
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Adult patients * Large vessel occlusion stroke

Exclusion criteria

* Intracranial hemorrhage, tumor, aneurism or vascular malformation i the stroke area * More than 24 hours after stroke onset

Design outcomes

Primary

MeasureTime frameDescription
Mortality3 monthsModified Rankin Scale. Minimum value 0 meaning perfect health without symptoms. Maximum value 6 meaning death.
Morbidity3 monthsModified Rankin Scale. Minimum value 0 meaning perfect health without symptoms. Maximum value 6 meaning death.
Symptomatic intracranial hemorrhageWithin 24 hours of treatmentAny intracranial hemorrhage with neurologic deterioration leading to an increase in NIHSS score ⬎4 or leading to death

Secondary

MeasureTime frameDescription
Time framesUp to 24 hoursTime periods based on stroke onset, hospital arrival, thrombectomy start, and end of procedure
Technical outcomeUp to 24 hoursReperfusion graded by modified Thrombolysis in Cerebral Infarction scale. Minimum value 0 meaning no reperfusion. Maximum value 3 meaning complete antegrade reperfusion of the previously occluded target artery ischemic territory, with absence of visualized occlusion in all distal branches
Simulation skillsUp to 5 yearsPerformance of simulator skills before and after a training period. The simulator software records time consumption (seconds), handling errors (number of turns, centimeter movement), fluoroscopy time (seconds), and radiation exposure (Grey per cm2)

Countries

Norway

Contacts

Primary ContactOlav Søvik, MD
olav.sovik@sshf.no+4741689421
Backup ContactPer Kristian Hyldmo, MD PhD
Per.K.Hyldmo@uis.no+4741600211

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026